Order a 2010 Digital Course
APPLYING NEXT GENERATION SEQUENCING TECHNOLOGIES TO RESEARCH
Tuesday, February 2, 2010 ● 9:00am – 12:00 noon ● Moscone North Convention Center, San Francisco, CA
Technologies for next generation sequencing are accelerating at a rapid pace. This digital course will present up-to-date information on the newest options for DNA sequencing, and the tools to manage the data. The major new advantages will be showcased in the latest platforms, and strategies for managing the data to turn it into useful information will be demonstrated by leaders in the field.
- Technologies for newest platforms next generation sequencing
- Strategies and tools for managing data
- Demonstration of how tools can be applied to research
Cambridge Healthtech Institute’s 17th International Molecular Medicine Tri-Conference.
About the Conference:
Molecular Medicine Tri-Conference -- the flagship event of CHI –built this year's event around 6 scientific channels providing attendees more learning opportunities than ever before. Featured channels include diagnostics, chemistry, informatics, biologics, cancer and executive. This expanded program provides attendees a more in depth experience into each of the six areas of research and development. As the need for better information, new technologies, improved strategies and competitive intelligence becomes ever more acute, this event provides compelling research insight into the future of molecular medicine. In 2010, the event drew over 2,700 attendees, 1200 participating companies, 150 exhibitors, 100 posters, and representatives from over 38 countries.
Agenda At A Glance:
Next-Gen Sequence Assembly and Cloud Computing
Francisco M. De La Vega, D.Sc., Distinguished Scientific Fellow, Computational Genomics Research, Genetics Systems R&D, Life Technologies
Biography: De La Vega is Principal Research Fellow in Genetics at Life Technologies in Foster City, CA. He earned his Doctor of Science degree in Genetics and Molecular Biology at CINVESTAV (Mexico City). In 1990 he was appointed assistant professor at CINVESTAV. De La Vega recently received the 2008 Bio-IT World Best Practices Award in Basic Research for the development of a pipeline to identify common disease susceptibility variants of functional significance in collaboration with Prof. Stefan Schreiber of the University of Kiel, Germany.
Using Wikis for Managing Next-Gen Sequencing Data
Giles Day, Senior Director, BBC Informatics, Pfizer Biotherapeutics & Bioinnovation Center
Biography: Day joined Pfizer in 1995 from Manchester University’s School of Biological Sciences where he completed a BSc in Biology and a MSc in Computational Biology. He spent 5 years at Pfizer UK helping to establish Bioinformatics as a discipline. In 2000 Day moved to the then Discovery Technology Center in Cambridge MA and the Research Informatics group. Following his role in Cambridge, Day spent a year leading the Target & Mechanism Informatics group, before moving to become head of informatics for Pfizer’s new research division, the Biotherapeutics and Bioinnovation Center (BBC) based in San Francisco.
Bioinformatics Analyst, Pfizer Global R&D Biotherapeutics Analyst, Pfizer Global R&D
Biography: Glanville earned a BA in molecular and cell biology at the University of California, Berkeley. "While there, a programming hobby and a Linux hobby turned into a work-related convenience," he says, when he joined a population genetics lab and started writing genomics software. "That's where I was until I was recruited by Giles to develop computational biology for the new BBC division" of Pfizer, he says. He brings to Pfizer his expertise with complex algorithms for sequence and structure analysis.
Emerging 3rd Generation Sequencing Technologies
Ronald W. Davis, Ph.D., Professor, Biochemistry & Genetics and Director, Stanford Genome Technology Center, Stanford University
Biography: Davis is currently a professor of biochemistry and genetics and director of the Stanford Genome Technology Center at Stanford University. His many honors include the 2005 Dickson Prize in Medicine, the University of Pittsburgh School of Medicine's most prestigious award; the Lifetime Achievement Award of the Genetics Society; the Herbert A. Sober Award; and the Genetics Society of America Award. After receiving his doctorate from Caltech, Davis held an NIH Postdoctoral Fellowship at Harvard University, then joined Stanford's department of biochemistry as an assistant professor in 1972. He became an associate professor in 1977, a professor in 1980, and a professor in the department of genetics in 1990. He was appointed director of the Stanford Genome Technology Center in 1994 and served in the senate of the Stanford University School of Medicine Faculty Council from 2000 to 2002.
Site License $1380
Over 135 minutes
More than 98 slides